| Origins of the E. coli Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany DA Rasko, DR Webster, JW Sahl, A Bashir, N Boisen, F Scheutz, ... New England Journal of Medicine 365 (8), 709-717, 2011 | 1096 | 2011 |
| An Outbreak of Multidrug-Resistant, Quinolone-Resistant Salmonella enterica Serotype Typhimurium DT104 K Mølbak, DL Baggesen, FM Aarestrup, JM Ebbesen, J Engberg, ... New England Journal of Medicine 341 (19), 1420-1425, 1999 | 687 | 1999 |
| Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study SI Halkjær, AH Christensen, BZS Lo, PD Browne, S Günther, LH Hansen, ... Gut 67 (12), 2107-2115, 2018 | 391 | 2018 |
| Genomic epidemiology of the Escherichia coli O104: H4 outbreaks in Europe, 2011 YH Grad, M Lipsitch, M Feldgarden, HM Arachchi, GC Cerqueira, ... Proceedings of the national academy of sciences 109 (8), 3065-3070, 2012 | 370 | 2012 |
| Virulence factors for hemolytic uremic syndrome, Denmark S Ethelberg, KEP Olsen, F Scheutz, C Jensen, P Schiellerup, J Engberg, ... Emerging infectious diseases 10 (5), 842, 2004 | 363 | 2004 |
| Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease HC Mirsepasi-Lauridsen, BA Vallance, KA Krogfelt, AM Petersen Clinical microbiology reviews 32 (2), 10.1128/cmr. 00060-18, 2019 | 328 | 2019 |
| Epidemiology and clinical manifestations of enteroaggregative Escherichia coli B Hebbelstrup Jensen, KEP Olsen, C Struve, KA Krogfelt, AM Petersen Clinical microbiology reviews 27 (3), 614-630, 2014 | 260 | 2014 |
| The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis M Prosberg, F Bendtsen, I Vind, AM Petersen, LL Gluud Scandinavian journal of gastroenterology 51 (12), 1407-1415, 2016 | 230 | 2016 |
| Helicobacter pylori: an invading microorganism? A review AM Petersen, KA Krogfelt FEMS Immunology & Medical Microbiology 36 (3), 117-126, 2003 | 184 | 2003 |
| Invasive listeriosis in Denmark 1994–2003: a review of 299 cases with special emphasis on risk factors for mortality P Gerner-Smidt, S Ethelberg, P Schiellerup, JJ Christensen, J Engberg, ... Clinical Microbiology and Infection 11 (8), 618-624, 2005 | 165 | 2005 |
| Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection L Vibholm, MH Schleimann, JF Højen, T Benfield, R Offersen, ... Clinical Infectious Diseases 64 (12), 1686-1695, 2017 | 159 | 2017 |
| Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial AM Petersen, H Mirsepasi, SI Halkjær, EM Mortensen, ... Journal of Crohn's and Colitis 8 (11), 1498-1505, 2014 | 142 | 2014 |
| Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis MK Vester-Andersen, HC Mirsepasi-Lauridsen, MV Prosberg, ... Scientific reports 9 (1), 13473, 2019 | 136 | 2019 |
| Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection AM Petersen, CR Stensvold, H Mirsepasi, J Engberg, A Friis-Møller, ... Scandinavian journal of gastroenterology 48 (5), 638-639, 2013 | 129 | 2013 |
| Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977–2013 B Kantsø, J Simonsen, S Hoffmann, P Valentiner-Branth, AM Petersen, ... Official journal of the American College of Gastroenterology| ACG 110 (11 …, 2015 | 105 | 2015 |
| Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies M Boyd, M Thodberg, M Vitezic, J Bornholdt, K Vitting-Seerup, Y Chen, ... Nature communications 9 (1), 1661, 2018 | 100 | 2018 |
| A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease AM Petersen, EM Nielsen, E Litrup, J Brynskov, H Mirsepasi, KA Krogfelt BMC microbiology 9, 1-7, 2009 | 96 | 2009 |
| A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease J Schölmerich, K Fellermann, FW Seibold, G Rogler, J Langhorst, ... Journal of Crohn's and Colitis 11 (4), 390-399, 2017 | 95 | 2017 |
| Microbial diversity in fecal samples depends on DNA extraction method: easyMag DNA extraction compared to QIAamp DNA stool mini kit extraction H Mirsepasi, S Persson, C Struve, LOB Andersen, AM Petersen, ... BMC research notes 7, 1-7, 2014 | 90 | 2014 |
| Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal M Agger, F Scheutz, S Villumsen, K Mølbak, AM Petersen Journal of Antimicrobial Chemotherapy 70 (9), 2440-2446, 2015 | 78 | 2015 |
Karen A KrogfeltProfessor, Roskilde University , DenmarkAdresse e-mail validée de ruc.dk
